Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis
NCT ID: NCT02796014
Last Updated: 2017-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
129 participants
OBSERVATIONAL
2016-05-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Psoriasis is a chronic disease which can be expected to have a significant impact on the quality of life of the patients and parents/family members alike. In line with this assumption, previous studies demonstrated that psoriasis psychosocially affects not only the patients, but also their close relatives. The psoriasis family index has been developed in an effort to objectively measure the health-related quality of life of the family members of patients with psoriasis. Nevertheless, data regarding the health-related quality of life of the parents of pediatric patients with psoriasis in the Turkish population are relatively scarce.
In study, the investigators primarily aim to utilize DeFIS to assess the impact of childhood psoriasis on the quality of life of the patients' parents. Further, the investigators attempt to investigate the relation between the quality of life of the patients and their parents, and reveal disease characteristics which might influence the quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PLANNED VISUAL EDUCATION ABOUT SKIN CANCER
NCT05788939
Providing Web-based Training to Parents Of Children With Leukemia
NCT06357585
The Turkish Version of Functional Disability Inventory
NCT05422456
The Relationship Between Functional Independence and Family Well-being in Children With Rare Genetic Disorders
NCT07348926
Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
NCT05539456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Parents unable to complete the questionnaire
* Patients with a serious medical disorder or in an emergency condition
3 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
OTHER_GOV
Haseki Training and Research Hospital
OTHER
Haydarpasa Numune Training and Research Hospital
OTHER
Istanbul Training and Research Hospital
OTHER_GOV
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
OTHER
Sisli Hamidiye Etfal Training and Research Hospital
OTHER
Istanbul Medeniyet University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
burak tekin
Dr, M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Burak Tekin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Istanbul Medeniyet University Goztepe Research and Training Hospital Department of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Medeniyet University Goztepe Research and Training Hospital
Istanbul, Kadikoy, Turkey (Türkiye)
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Istanbul, , Turkey (Türkiye)
Haseki Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Haydarpasa Numune Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Istanbul Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Okmeydani Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Sisli Etfal Training & Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994 May;19(3):210-6. doi: 10.1111/j.1365-2230.1994.tb01167.x.
Gurel MS, Yanik M, Simsek Z, Kati M, Karaman A. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol. 2005 Nov;44(11):933-8. doi: 10.1111/j.1365-4632.2004.02225.x.
Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995 Jun;132(6):942-9. doi: 10.1111/j.1365-2133.1995.tb16953.x.
Basra MK, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol. 2007 Mar;156(3):528-38. doi: 10.1111/j.1365-2133.2006.07617.x.
Eghlileb AM, Basra MK, Finlay AY. The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis. Dermatology. 2009;219(1):63-70. doi: 10.1159/000209234. Epub 2009 Mar 13.
Tadros A, Vergou T, Stratigos AJ, Tzavara C, Hletsos M, Katsambas A, Antoniou C. Psoriasis: is it the tip of the iceberg for the quality of life of patients and their families? J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1282-7. doi: 10.1111/j.1468-3083.2010.03965.x. Epub 2011 Jan 17.
Ganemo A, Wahlgren CF, Svensson A. Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol. 2011 Jul-Aug;28(4):375-9. doi: 10.1111/j.1525-1470.2010.01292.x. Epub 2011 Jul 8.
Related Links
Access external resources that provide additional context or updates about the study.
Development and preliminary validation of the dermatological family impact scale
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/0118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.